HDFC Pharma and Healthcare Fund - Direct - Growth

Equity Scheme by HDFC Asset Management Company Limited

1Y Returns (CAGR)
20.03%
Expense Ratio
0.93%

as of 01/03/2026

AUM
₹644.16 Cr

Qtr End: Mar 26

NAV
₹21.51

as of 17/07/2026

Historical Performance
Investment growth and SIP performance over time.
Performance Metrics
Returns, CAGR, and Volatility.
Period
Returns
CAGR
Volatility
3M17.13%88.23%11.89%
6M23.83%53.35%14.66%
1Y20.03%20.03%13.37%
3YN/AN/AN/A
5YN/AN/AN/A
Scheme Details
Launch Date
14/09/2023
Fund Age
2.8 years
Minimum Investment
₹100
Fund House
HDFC Mutual Fund
Category
Equity Scheme
Sub-category
Sectoral/ Thematic (Equity Scheme)

Frequently Asked Questions